银屑病关节炎的机会窗口:越早越好?
研究纳入荷兰西南部早期银屑病关节炎队列中708例新诊断、未使用改善病情抗风湿药且随访≥3年的患者,按总延迟分为短(<12周)、中(12周至1年)、长(>1年)三组。短延迟组较长延迟组更易达到最小疾病活动度(OR 2.55,p=0.003)和DAPSA缓解(OR 2.35,p=0.004)。女性、附着点炎、慢性背痛或CRP正常者延迟更长。
要点
- 总延迟<12周者较长延迟者更易达到MDA(OR 2.55,p=0.003)和DAPSA缓解(OR 2.35,p=0.004)。
- 患者延迟为1.0个月,医生延迟为4.5个月。
- 女性、附着点炎、慢性背痛或CRP正常者延迟更长。
核心结论
- 在银屑病关节炎中,1年内转诊和诊断与更好的临床结局相关,提示存在机会窗口。
- 转诊的最大改善空间在医生延迟以及女性、附着点炎、慢性背痛或CRP正常的患者。
研究设计与样本
- 研究纳入荷兰西南部早期银屑病关节炎队列中所有新诊断、未使用改善病情抗风湿药且随访≥3年的银屑病关节炎患者,共708例。
- 总延迟计算为症状发作至风湿科医生诊断银屑病关节炎的时间,并分为患者延迟和医生延迟;总延迟分为短(<12周)、中(12周至1年)、长(>1年)三组。
- 比较三组在3年随访期间的临床结局(最小疾病活动度和DAPSA缓解)及患者报告结局。
主要发现
- 708例患者中,短、中、长总延迟分别为136例(19%)、237例(33%)和335例(47%)。
- 患者延迟为1.0个月,医生延迟为4.5个月。
- 与长延迟组相比,短延迟组更易达到最小疾病活动度(OR 2.55,p=0.003)和DAPSA缓解(OR 2.35,p=0.004)。
- 短延迟组与长延迟组的患者报告结局显示数值差异但无统计学显著性。
- 女性以及以附着点炎、慢性背痛或C反应蛋白正常表现的患者延迟更长。
关键数值与推荐
- 总延迟分类:短<12周,中12周至1年,长>1年。
- 短延迟组较长延迟组达到最小疾病活动度的OR为2.55(p=0.003)。
- 短延迟组较长延迟组达到DAPSA缓解的OR为2.35(p=0.004)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate whether there is a window of opportunity for psoriatic arthritis (PsA) patients and to assess which patient characteristics are associated with a longer diagnostic delay. METHODS: All newly diagnosed, disease-modifying antirheumatic drug-naïve PsA patients who participated in the Dutch southwest Early PsA cohoRt and had ≥3 years of follow-up were studied. First, total delay was calculated as the time period between symptom onset and PsA diagnosis made by a rheumatologist and then split into patient and physician delays. The total delay was categorised into short (<12 weeks), intermediate (12 weeks to 1 year) or long (>1 year). These groups were compared on clinical (Minimal Disease Activity (MDA) and Disease Activity index for PSoriatic Arthritis (DAPSA) remission) and patient-reported outcomes during 3 years follow-up. RESULTS: 708 PsA patients were studied of whom 136 (19%), 237 (33%) and 335 (47%) had a short, intermediate and long total delay, respectively. Patient delay was 1.0 month and physician delay was 4.5 months. Patients with a short delay were more likely to achieve MDA (OR 2.55, p=0.003) and DAPSA remission (OR 2.35,p=0.004) compared with PsA patients with a long delay. Patient-reported outcomes showed numerical but non-significant differences between the short and long delay groups. Female patients and those presenting with enthesitis, chronic back pain or normal C-reactive protein (CRP) had a longer delay. CONCLUSIONS: In PsA, referral and diagnosis within 1 year is associated with better clinical outcomes, suggesting the presence of a window of opportunity. The most gain in referral could be obtained in physician delay and in females, patients with enthesitis, chronic back pain or normal CRP.
引用
- Snoeck Henkemans SVJ, de Jong PHP, Luime JJ, et al. Window of opportunity in psoriatic arthritis: the earlier the better? RMD Open. 2024. PMID: 38413172. doi:10.1136/rmdopen-2023-004062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。